SI2442799T2 - Trden farmacevtski sestavek, ki obsega rivaroksaban - Google Patents

Trden farmacevtski sestavek, ki obsega rivaroksaban

Info

Publication number
SI2442799T2
SI2442799T2 SI201031344T SI201031344T SI2442799T2 SI 2442799 T2 SI2442799 T2 SI 2442799T2 SI 201031344 T SI201031344 T SI 201031344T SI 201031344 T SI201031344 T SI 201031344T SI 2442799 T2 SI2442799 T2 SI 2442799T2
Authority
SI
Slovenia
Prior art keywords
rivaroxaban
pharmaceutical composition
solid pharmaceutical
solid
composition
Prior art date
Application number
SI201031344T
Other languages
English (en)
Other versions
SI2442799T1 (sl
Inventor
Gregor Sedmak
Franc Vrecer
Klavdija Meznar
Sabina Trost
Polona Bukovec
Miran Hvalec
Original Assignee
Krka, Tovarna Zdravil D.D., Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42352709&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2442799(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP09163177A external-priority patent/EP2266541A1/en
Application filed by Krka, Tovarna Zdravil D.D., Novo Mesto filed Critical Krka, Tovarna Zdravil D.D., Novo Mesto
Publication of SI2442799T1 publication Critical patent/SI2442799T1/sl
Publication of SI2442799T2 publication Critical patent/SI2442799T2/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
SI201031344T 2009-06-18 2010-06-18 Trden farmacevtski sestavek, ki obsega rivaroksaban SI2442799T2 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP09163177A EP2266541A1 (en) 2009-06-18 2009-06-18 Solid pharmaceutical composition comprising rivaroxaban
EP10156445 2010-03-12
PCT/EP2010/058680 WO2010146179A2 (en) 2009-06-18 2010-06-18 Solid pharmaceutical composition comprising rivaroxaban
EP10725746.1A EP2442799B2 (en) 2009-06-18 2010-06-18 Solid pharmaceutical composition comprising rivaroxaban

Publications (2)

Publication Number Publication Date
SI2442799T1 SI2442799T1 (sl) 2017-02-28
SI2442799T2 true SI2442799T2 (sl) 2019-08-30

Family

ID=42352709

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201031344T SI2442799T2 (sl) 2009-06-18 2010-06-18 Trden farmacevtski sestavek, ki obsega rivaroksaban

Country Status (11)

Country Link
EP (1) EP2442799B2 (sl)
DK (1) DK2442799T3 (sl)
EA (1) EA035562B1 (sl)
ES (1) ES2606127T5 (sl)
HR (1) HRP20161617T4 (sl)
HU (1) HUE031177T2 (sl)
LT (1) LT2442799T (sl)
PL (1) PL2442799T5 (sl)
PT (1) PT2442799T (sl)
SI (1) SI2442799T2 (sl)
WO (1) WO2010146179A2 (sl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130064888A1 (en) 2011-08-08 2013-03-14 Roey Solomonovich Pharmaceutical formulations
EP2935255B1 (en) 2012-12-21 2017-08-16 Farma GRS, d.o.o. A process for preparation of rivaroxaban
EP2808011A1 (en) * 2013-05-29 2014-12-03 Sandoz Ag Process for the preparation of a pharmaceutical composition comprising Rivaroxaban
WO2015097090A1 (en) * 2013-12-23 2015-07-02 Laboratorios Del Dr. Esteve, S.A. Oral pharmaceutical composition
WO2015124995A1 (en) 2014-02-19 2015-08-27 Aurobindo Pharma Ltd Solid dosage forms of rivaroxaban
CN104055743B (zh) * 2014-06-10 2016-01-06 吉林省博大制药有限责任公司 一种含利伐沙班口服制剂的制备方法
TR201501970A2 (en) * 2015-02-19 2016-09-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical combinations of dronedarone.
KR101818761B1 (ko) * 2015-03-06 2018-01-15 에스케이케미칼 주식회사 리바록사반을 포함하는 약학제제
WO2016166733A1 (en) * 2015-04-17 2016-10-20 Micro Labs Limited A process for preparing a pharmaceutical composition comprising rivaroxaban
EP3331503A1 (en) * 2015-08-05 2018-06-13 Interquim, S.A. Rivaroxaban pharmaceutical compositions
CN105078915A (zh) * 2015-08-27 2015-11-25 江苏中邦制药有限公司 一种利伐沙班片及其制备方法
US20190046449A1 (en) * 2016-02-25 2019-02-14 Mylan Inc. A unique high-shear granulation process for improved bioavailability of rivaroxaban
WO2018001914A1 (en) * 2016-06-28 2018-01-04 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical capsule composition of rivaroxaban
WO2018007945A1 (en) * 2016-07-05 2018-01-11 Alphamed Formulations Pvt. Ltd Solid composition containing oral anticoagulant
EP3505160A1 (en) 2017-12-31 2019-07-03 Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. Preparation of a solid pharmaceutical composition comprising rivaroxaban and production thereof
GR1009619B (el) * 2018-05-09 2019-10-23 Φαρμαζακ Α.Φ.Ε.Β.Ε. Φαρμακευτικη συνθεση που περιεχει ριβαροξαβανη και μεθοδος για την παρασκευη αυτης
EP3796915A4 (en) * 2018-11-16 2022-01-26 Santa Farma Ilaç Sanayi A.S. ORAL FORMULATIONS CONTAINING RIVAROXABAN
EP4208462A1 (en) * 2020-09-05 2023-07-12 Inventia Healthcare Limited Rivaroxaban compositions
WO2022259118A1 (en) * 2021-06-10 2022-12-15 Shilpa Medicare Limited Fast dissolving oral film preparation comprising rivaroxaban

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10355461A1 (de) * 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
KR101364400B1 (ko) 2005-10-04 2014-02-17 바이엘 인텔렉쳐 프로퍼티 게엠베하 5-클로로-ｎ-(｛(5ｓ)-2-옥소-3-［4-(3-옥소-4-모르폴리닐)-페닐］-1,3-옥사졸리딘-5-일｝-메틸)-2-티오펜 카르복사미드의 신규 다형체 및 무정형 형태
DE102005047561A1 (de) * 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102007048705A1 (de) 2007-10-11 2009-04-16 Bayer Healthcare Ag Amorphe Formulierung
RU2011104360A (ru) * 2008-07-08 2012-08-20 Рациофарм ГмбХ (DE) Фармацевтические соединения, содержащие 5-хлор-n-({(5s)-2-оксо-3-[4-(3-оксо-4-морфолинил)-фенил]-1,3-оксазолидин-5-ил}-митил)-2-тиофенкарбоксамид
CA2733611A1 (en) * 2008-08-11 2010-02-18 Ratiopharm Gmbh Pharmaceutical compositions with modified release properties comprising 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid

Also Published As

Publication number Publication date
HUE031177T2 (hu) 2017-07-28
WO2010146179A2 (en) 2010-12-23
LT2442799T (lt) 2016-12-27
EP2442799A2 (en) 2012-04-25
ES2606127T5 (es) 2020-02-17
PL2442799T3 (pl) 2017-04-28
EA035562B1 (ru) 2020-07-08
WO2010146179A3 (en) 2011-04-14
PT2442799T (pt) 2016-12-07
HRP20161617T4 (hr) 2019-06-28
HRP20161617T1 (hr) 2017-01-13
EP2442799B1 (en) 2016-09-07
ES2606127T3 (es) 2017-03-22
PL2442799T5 (pl) 2019-09-30
DK2442799T3 (da) 2017-01-02
EP2442799B2 (en) 2019-05-22
EA201190319A1 (ru) 2012-06-29
SI2442799T1 (sl) 2017-02-28

Similar Documents

Publication Publication Date Title
HRP20161617T1 (hr) Čvrsti farmaceutski sastav koji sadrži rivaroksaban
HK1231408A1 (zh) 藥物組合物
IL228817A0 (en) Pharmaceutical compounds
EP2451274A4 (en) PHARMACEUTICAL COMPOSITIONS
EP2419097A4 (en) PHARMACEUTICAL COMPOSITIONS
EP2379077A4 (en) PHARMACEUTICAL COMPOSITION
IL218937A0 (en) Pharmaceutical compositions comprising rivaroxaban
ZA201102715B (en) Solid pharmaceutical composition
IL208387A0 (en) Pharmaceutical composition
ZA201104670B (en) Pharmaceutical composition comprising aleglitazar
ZA201100871B (en) Solid pharmaceutical composition
ZA201006224B (en) Pharmaceutical composition
GB2464200B (en) Pharmaceutical composition
EP2488175A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0919650D0 (en) Pharmaceutical composition
GB0817969D0 (en) Pharmaceutical composition
HU0900010D0 (en) Improved pharmaceutical composition
HU0800741D0 (en) Improved pharmaceutical composition
GB0817974D0 (en) Pharmaceutical composition
GB0817566D0 (en) Pharmaceutical composition